210 related articles for article (PubMed ID: 31984527)
1. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding.
Dourado MR; Miwa KYM; Hamada GB; Paranaíba LMR; Sawazaki-Calone Í; Domingueti CB; Ervolino de Oliveira C; Furlan ECB; Longo BC; Almangush A; Salo T; Coletta RD
Histopathology; 2020 May; 76(6):906-918. PubMed ID: 31984527
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
3. Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma.
Kang J; Su M; Xu Q; Wang C; Yuan X; Han Z
Oral Dis; 2023 Mar; 29(2):628-638. PubMed ID: 34455659
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
5. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
[TBL] [Abstract][Full Text] [Related]
6. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma.
Mascitti M; Zhurakivska K; Togni L; Caponio VCA; Almangush A; Balercia P; Balercia A; Rubini C; Lo Muzio L; Santarelli A; Troiano G
Histopathology; 2020 Nov; 77(5):810-822. PubMed ID: 32633006
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor-stroma ratio in oral carcinoma: Role of cancer-associated fibroblasts.
Qiu J; Jiang E; Shang Z
Oral Dis; 2023 Jul; 29(5):1967-1978. PubMed ID: 35388593
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
10. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system.
Boxberg M; Jesinghaus M; Dorfner C; Mogler C; Drecoll E; Warth A; Steiger K; Bollwein C; Meyer P; Wolff KD; Kolk A; Weichert W
Histopathology; 2017 Jun; 70(7):1125-1137. PubMed ID: 28122134
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
[TBL] [Abstract][Full Text] [Related]
12. Tumor-stroma ratio is a crucial histological predictor of occult cervical lymph node metastasis and survival in early-stage (cT1/2N0) oral squamous cell carcinoma.
Huang S; Cai H; Song F; Zhu Y; Hou C; Hou J
Int J Oral Maxillofac Surg; 2022 Apr; 51(4):450-458. PubMed ID: 34412929
[TBL] [Abstract][Full Text] [Related]
13. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
14. Role of tumor budding and fibrotic cancer stroma in head and neck squamous cell carcinoma.
Mitha M; Aden D; Zaheer S; Alvi Y; Chintamani
Pathol Res Pract; 2024 Jan; 253():155052. PubMed ID: 38176309
[TBL] [Abstract][Full Text] [Related]
15. Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma.
Seki M; Sano T; Yokoo S; Oyama T
Histopathology; 2017 May; 70(6):869-879. PubMed ID: 27926795
[TBL] [Abstract][Full Text] [Related]
16. Multiperspective quantitative tumor-stroma ratio reveals histological areas associated with poor outcomes in oral squamous cell carcinoma.
Wang S; Si Q; Wu Y; Sun Y; Zhang W; Huang X; Zeng T; Chen S; Yang X; Ni Y; Hu Q
Cancer Med; 2023 Jun; 12(11):12161-12172. PubMed ID: 37184217
[TBL] [Abstract][Full Text] [Related]
17. Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
Sakai T; Saito Y; Tateishi Y; Yamazawa S; Fukuoka O; Kobayashi K; Omura G; Akashi K; Yoshida M; Ando M; Ebihara Y; Yamasoba T
Int J Clin Oncol; 2022 Dec; 27(12):1818-1827. PubMed ID: 36197545
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
[TBL] [Abstract][Full Text] [Related]
19. Tumour budding and tumour-stroma ratio in hepatocellular carcinoma.
Kairaluoma V; Kemi N; Pohjanen VM; Saarnio J; Helminen O
Br J Cancer; 2020 Jul; 123(1):38-45. PubMed ID: 32362654
[TBL] [Abstract][Full Text] [Related]
20. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
Niranjan KC; Raj M; Hallikeri K
Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
